Abstract 6941: Preclinical efficacy of the CK1 alpha/CDK7/CDK9 inhibitor BTX-A51 in <i>CIC</i>-rearranged sarcoma

Authors: Quentin Odom-Lewis, Samantha L. Davis, Stephan Pieper, Chen Chu, Emanuele Mazzola, Renyan Liu, Nicole Solimini, Prafulla C. Gokhale, Geoffrey I. Shapiro, George D. Demetri, Inga-Marie Schaefer

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-6941

Source: Full article